Evaluating the Efficacy of Opti-Speech for Speech Treatment

NCT02705326 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Vulintus, Inc.

Collaborators